Viewing Study NCT00375193


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-01-25 @ 11:55 AM
Study NCT ID: NCT00375193
Status: COMPLETED
Last Update Posted: 2019-10-24
First Post: 2006-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None small cell lung cancer View
None amrubicin View